Late-Stage Upfront Payments Hit New Highs
Executive SummaryLicensing fees for late stage products are at an all-time high--we examine upfront payments in pharmaceuticals over the past twelve months.
You may also be interested in...
ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.
Crude heparin supplier Yibin Lihao headlines list of facilities in 12 countries added to the US FDA’s drug GMP import alert.